GlassScriptPhysician profile
Sushruth Edla
NPI 1821343179
$15,814.46
in general payments reported to CMS, 2019-2025
33 companies · $2,693 in 2025
The $2,693 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,023 · 2020: $1,003 · 2021: $1,343 · 2022: $1,937 · 2023: $2,347 · 2024: $2,469 · 2025: $2,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,017 · Travel and Lodging: $1,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,016.56 |
| Travel and Lodging | $1,492.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,536.17 | 2019-2025 | Diamondback Peripheral, Jot Dx, Amplatzer Talisman |
| Edwards Lifesciences Corporation | $2,058.28 | 2020-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $1,978.18 | 2019-2025 | Impella |
| Medtronic, INC. | $1,765.90 | 2021-2025 | Micra, Onyx Frontier, Symplicity G3 |
| Medtronic Vascular, INC. | $1,708.80 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,016.39 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $821.15 | 2019-2025 | Synergy, Emerge Push, Wolverine Coronary Cutting Balloon |
| Shockwave Medical, INC | $593.65 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $453.38 | 2021-2025 | Indigo System |
| Janssen Pharmaceuticals, INC | $373.61 | 2019-2023 | Xarelto |
| Cardiovascular Systems INC. | $366.03 | 2021-2023 | Diamondback Peripheral |
| Teleflex LLC | $272.74 | 2022-2023 | Vsi |
| Novartis Pharmaceuticals Corporation | $272.29 | 2019-2025 | |
| Philips North America LLC | $267.55 | 2019-2024 | (Az7) Lasers |
| Amgen INC. | $220.55 | 2019-2025 | Repatha, Repatha |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $199.10 | 2019-2023 | |
| Inari Medical, INC. | $160.22 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $120.12 | 2019-2022 | |
| Biotronik INC. | $112.04 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $107.98 | 2020-2025 | Eliquis, Camzyos |
| Cardinal Health 200 LLC | $104.17 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.45 | 2025 | Jardiance |
| Stryker Corporation | $45.83 | 2025 | Clottriever Bold Catheter |
| Angiodynamics, INC. | $32.68 | 2024 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $25.99 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $24.64 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $23.55 | 2024 | |
| Zoll Circulation INC | $22.63 | 2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Lexicon Pharmaceuticals, INC. | $19.86 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $18.07 | 2023 | |
| Esperion Therapeutics, INC. | $15.27 | 2021 | |
| Cook Medical LLC | $14.69 | 2023 | Zilver Ptx |
| Impulse Dynamics (USA) INC. | $13.50 | 2025 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sushruth Edla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.